Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 9294E OLANZAPINEolanzapine 210 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack 2 2 5
MPNP 1041T OLANZAPINEolanzapine 7.5 mg tablet, 28 1 28 5
MPNP 8186W OLANZAPINEolanzapine 7.5 mg tablet, 28 1 28 5
MPNP 1042W OLANZAPINEolanzapine 10 mg tablet, 28 1 28 5
MPNP 8187X OLANZAPINEolanzapine 10 mg tablet, 28 1 28 5
MPNP 8433W OLANZAPINEolanzapine 5 mg wafer, 28 1 28 5
MPNP 9295F OLANZAPINEolanzapine 300 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack 2 2 5
MPNP 1037N OLANZAPINEolanzapine 5 mg tablet, 28 1 28 5
MPNP 8185T OLANZAPINEolanzapine 5 mg tablet, 28 1 28 5
MPNP 3385E OLANZAPINEolanzapine 20 mg orally disintegrating tablet, 28 1 28 5
MPNP 3382B OLANZAPINEolanzapine 10 mg orally disintegrating tablet, 28 1 28 5
MPNP 8170B OLANZAPINEolanzapine 2.5 mg tablet, 28 1 28 5
MPNP 8434X OLANZAPINEolanzapine 10 mg wafer, 28 1 28 5
MPNP 3384D OLANZAPINEolanzapine 15 mg orally disintegrating tablet, 28 1 28 5
MPNP 3381Y OLANZAPINEolanzapine 5 mg orally disintegrating tablet, 28 1 28 5
MPNP 9303P OLANZAPINEolanzapine 405 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack 1 1 5
MPNP 8952E OLANZAPINEolanzapine 15 mg wafer, 28 1 28 5
MPNP 8953F OLANZAPINEolanzapine 20 mg wafer, 28 1 28 5
MPNP 2147B OLMESARTANolmesartan medoxomil 20 mg tablet, 30 1 30 5
MPNP 2148C OLMESARTANolmesartan medoxomil 40 mg tablet, 30 1 30 5
MPNP 2836G OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDEolmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 2953K OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDEolmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 1 30 5
MPNP 10005N OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDEolmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 2864R OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDEolmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 1 30 5
MPNP 2880N OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDEolmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 5294P OLMESARTAN MEDOXOMIL + AMLODIPINEolmesartan medoxomil 40 mg + amlodipine 10 mg tablet, 30 1 30 5
MPNP 5292M OLMESARTAN MEDOXOMIL + AMLODIPINEolmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 1 30 5
MPNP 5293N OLMESARTAN MEDOXOMIL + AMLODIPINEolmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 1 30 5
MPNP 2170F OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDEolmesartan medoxomil 40 mg + hydrochlorothiazide 25 mg tablet, 30 1 30 5
MPNP 2161R OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDEolmesartan medoxomil 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 2166B OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDEolmesartan medoxomil 40 mg + hydrochlorothiazide 12.5 mg tablet, 30 1 30 5
MPNP 1728Y OLSALAZINEolsalazine sodium 250 mg capsule, 100 1 100 5
MPNP 8086N OLSALAZINEolsalazine sodium 500 mg tablet, 100 1 100 5
MPNP 8332M OMEPRAZOLEomeprazole 10 mg enteric tablet, 30 1 30 5
MPNP 8331L OMEPRAZOLEomeprazole 20 mg enteric tablet, 30 1 30 1
MPNP 8333N OMEPRAZOLEomeprazole 20 mg enteric tablet, 30 1 30 5
MPNP 9109K OMEPRAZOLEomeprazole 20 mg enteric tablet, 30 1 30 1
MPNP 9110L OMEPRAZOLEomeprazole 20 mg enteric tablet, 30 1 30 5
MPNP 1326T OMEPRAZOLEomeprazole 20 mg enteric capsule, 30 1 30 1
MPNP 1327W OMEPRAZOLEomeprazole 20 mg enteric capsule, 30 1 30 5
MPNP 8411Q ONDANSETRONondansetron 8 mg wafer, 4 1 4 0
MPNP 8410P ONDANSETRONondansetron 4 mg wafer, 4 1 4 0
MPNP 5472B ONDANSETRONondansetron 4 mg orally disintegrating tablet, 10 1 10 1
MPNP 5471Y ONDANSETRONondansetron 8 mg orally disintegrating tablet, 4 1 4 0
MPNP 1594X ONDANSETRONondansetron 4 mg tablet, 10 1 10 1
MPNP 8412R ONDANSETRONondansetron 4 mg wafer, 10 1 10 1
MPNP 1596B ONDANSETRONondansetron 4 mg/2 mL injection, 2 mL ampoule 1 1 0
MPNP 8226Y ONDANSETRONondansetron 4 mg/2 mL injection, 2 mL ampoule 1 1 0
MPNP 1597C ONDANSETRONondansetron 8 mg/4 mL injection, 4 mL ampoule 1 1 0
MPNP 8227B ONDANSETRONondansetron 8 mg/4 mL injection, 4 mL ampoule 1 1 0
MPNP 8225X ONDANSETRONondansetron 8 mg tablet, 4 1 4 0
MPNP 1595Y ONDANSETRONondansetron 8 mg tablet, 10 1 10 1
MPNP 8233H ONDANSETRONondansetron 4 mg/5 mL oral liquid, 50 mL 1 1 1
MPNP 9441X ONDANSETRONondansetron 4 mg/5 mL oral liquid, 50 mL 1 1 0
MPNP 5470X ONDANSETRONondansetron 4 mg orally disintegrating tablet, 4 1 4 0
MPNP 8413T ONDANSETRONondansetron 8 mg wafer, 10 1 10 1
MPNP 8224W ONDANSETRONondansetron 4 mg tablet, 4 1 4 0
MPNP 5473C ONDANSETRONondansetron 8 mg orally disintegrating tablet, 10 1 10 1
MPNP 3133X OXAZEPAMoxazepam 30 mg tablet, 25 1 25 0
MPNP 3135B OXAZEPAMoxazepam 30 mg tablet, 25 2 50 5
MPNP 5372R OXAZEPAMoxazepam 30 mg tablet, 25 2 50 3
MPNP 3132W OXAZEPAMoxazepam 15 mg tablet, 25 1 25 0
MPNP 3134Y OXAZEPAMoxazepam 15 mg tablet, 25 2 50 5
MPNP 5371Q OXAZEPAMoxazepam 15 mg tablet, 25 2 50 3
MPNP 8588B OXCARBAZEPINEoxcarbazepine 60 mg/mL oral liquid, 250 mL 2 2 5
MPNP 8586X OXCARBAZEPINEoxcarbazepine 600 mg tablet, 100 1 100 5
MPNP 8585W OXCARBAZEPINEoxcarbazepine 300 mg tablet, 100 1 100 5
MPNP 8584T OXCARBAZEPINEoxcarbazepine 150 mg tablet, 100 1 100 5
MPNP 2961W OXPRENOLOLoxprenolol hydrochloride 40 mg tablet, 100 1 100 5
MPNP 8039D OXYBUTYNINoxybutynin hydrochloride 5 mg tablet, 100 1 100 5
MPNP 9454N OXYBUTYNINoxybutynin 3.9 mg/24 hours patch, 8 1 1 5
MPNP 8386J OXYCODONEoxycodone hydrochloride 20 mg modified release tablet, 28 1 28 0
MPNP 8501K OXYCODONEoxycodone hydrochloride 10 mg capsule, 20 1 20 0
MPNP 9400R OXYCODONEoxycodone hydrochloride 30 mg modified release tablet, 28 1 28 0
MPNP 8464L OXYCODONEoxycodone hydrochloride 5 mg capsule, 20 1 20 0
MPNP 8644Y OXYCODONEoxycodone hydrochloride 1 mg/mL oral liquid, 250 mL 1 1 0
MPNP 2481N OXYCODONEoxycodone 30 mg suppository, 12 1 12 0
MPNP 9399Q OXYCODONEoxycodone hydrochloride 15 mg modified release tablet, 28 1 28 0
MPNP 8502L OXYCODONEoxycodone hydrochloride 20 mg capsule, 20 1 20 0
MPNP 8388L OXYCODONEoxycodone hydrochloride 80 mg modified release tablet, 28 1 28 0
MPNP 8385H OXYCODONEoxycodone hydrochloride 10 mg modified release tablet, 28 1 28 0
MPNP 8387K OXYCODONEoxycodone hydrochloride 40 mg modified release tablet, 28 1 28 0
MPNP 2622B OXYCODONEoxycodone hydrochloride 5 mg tablet, 20 1 20 0
MPNP 11111T OXYCODONE + NALOXONEoxycodone hydrochloride 80 mg + naloxone hydrochloride 40 mg modified release tablet, 28 1 28 0
MPNP 10758F OXYCODONE + NALOXONEoxycodone hydrochloride 30 mg + naloxone hydrochloride 15 mg modified release tablet, 28 1 28 0
MPNP 8936H OXYCODONE + NALOXONEoxycodone hydrochloride 40 mg + naloxone hydrochloride 20 mg modified release tablet, 28 1 28 0
MPNP 10776E OXYCODONE + NALOXONEoxycodone hydrochloride 2.5 mg + naloxone hydrochloride 1.25 mg modified release tablet, 28 1 28 0
MPNP 8934F OXYCODONE + NALOXONEoxycodone hydrochloride 10 mg + naloxone hydrochloride 5 mg modified release tablet, 28 1 28 0
MPNP 8000C OXYCODONE + NALOXONEoxycodone hydrochloride 5 mg + naloxone hydrochloride 2.5 mg modified release tablet, 28 1 28 0
MPNP 8935G OXYCODONE + NALOXONEoxycodone hydrochloride 20 mg + naloxone hydrochloride 10 mg modified release tablet, 28 1 28 0
MPNP 11102H OXYCODONE + NALOXONEoxycodone hydrochloride 60 mg + naloxone hydrochloride 30 mg modified release tablet, 28 1 28 0
MPNP 10757E OXYCODONE + NALOXONEoxycodone hydrochloride 15 mg + naloxone hydrochloride 7.5 mg modified release tablet, 28 1 28 0